1. C. LY, G. SD and H. J, Fusion and nonsurgical treatment for symptomatic lumbar degenerative disease: a systematic review of Oswestry Disability Index and MOS Short Form-36 outcomes, The spine journal : official journal of the North American Spine Society 8 (2008), pp. 747-755.
2. P. FM, S. PJ, Y. JA, A. G and P. F, Lumbar spine fusion for chronic low back pain due to degenerative disc disease: a systematic review, Spine 38 (2013), pp. E409-422.
3. S. K, N. SV, M.-L. A and F. SJ, Epidemiological trends in the utilization of bone morphogenetic protein in spinal fusions from 2002 to 2011, Spine 39 (2014), pp. 491-496.
4. L. SP, N. JK and B. M, Trends in the use of bone morphogenetic protein as a substitute to autologous iliac crest bone grafting for spinal fusion procedures in the United States, Spine 36 (2011), pp. E274-281.
5. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures;Kevin s;JAMA,2009